BeStock  
Stocks › Biotechnology › RGNX

Regenxbio RGNX

US equityMarket cap rank #3741Biotechnology
$7.56 −$0.04 (-0.53%)
Market open · Oct 8, 10:00 am ET · After hours $7.61 +0.21%
Open$7.50
Prev close$7.60
Day range$7.44 – $7.58
Volume82.9K
Market cap$498.73M
P/E (TTM)–
Dividend yield–

RGNX Stock News

Headlines matching Regenxbio or the RGNX ticker, most recent first.

  • H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $21Market news · 28 Sep 2026 · Direct mention
  • Stifel Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $42Market news · 25 Sep 2026 · Direct mention
  • BofA Securities Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $15Market news · 21 Sep 2026 · Direct mention
  • BofA Securities Maintains Regenxbio(RGNX.US) With Buy Rating, Raises Target Price to $15 PositiveMarket news · 8 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Regenxbio(RGNX.US), With a Forecast Between $12 to $45Market news · 7 Aug 2026 · Direct mention
  • Morgan Stanley Maintains Regenxbio(RGNX.US) With Buy Rating, Raises Target Price to $18 PositiveMarket news · 7 Aug 2026 · Direct mention
  • Clear Street Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $45Market news · 3 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Cuts Target Price to $21 NegativeMarket news · 26 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Regenxbio(RGNX.US), With a Forecast Between $15 to $32Market news · 25 Aug 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Sagimet Biosciences, Inc. Class A (SGMT)TipRanks · 25 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Cuts Target Price to $23 NegativeMarket news · 10 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $26Market news · 1 Jul 2026 · Direct mention
  • H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Cuts Target Price to $26 NegativeMarket news · 6 Jun 2026 · Direct mention
  • Morgan Stanley Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $16Market news · 25 Jun 2026 · Direct mention
  • Baird Maintains Regenxbio(RGNX.US) With Buy Rating, Raises Target Price to $32 PositiveMarket news · 23 Jun 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on RGNX.

Leave a comment

Scroll to Top